Barrowclough, C, Haddock, G, Tarrier, N, et al. (2001) Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158: 1706–13.
Barrowclough, C, Haddock, G, Wykes, T, et al. (2010) Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical Research Edn), 341: c6325.
Barrowclough, C, Marshall, M, Gregg, L, et al. (2014) A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine, 44: 2749–61.
Burns, T (2009) End of the road for treatment-as-usual studies? British Journal of Psychiatry, 195: 5–6.
Cao, J, Zhu, J, Xu, L, et al. (2014) Study on the effects of cognitive-behavioral intervention on the rehabilitation of first-episode schizophrenia. Journal of Psychiatry, 27: 297–9.
D'Agostino, A, Rossi Monti, M, Starcevic, V (2019) Psychotic symptoms in borderline personality disorder: an update. Current Opinion in Psychiatry, 32: 22–26.
Freedland, KE, Mohr, DC, Davidson, KW, et al. (2011) Usual and unusual care: existing practice control groups in randomized controlled trials of behavioural interventions. Psychosomatic Medicine, 73: 323–35.
Gleeson, JFM, Cotton, SM, Alvarez-Jimenez, M, et al. (2009) A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. Journal of Clinical Psychiatry, 70: 477–86.
Grawe, RW, Falloon, IR, Widen, JH, et al. (2006) Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica, 114: 328–36.
Gumley, A, O'Grady, M, McNay, L, et al. (2003) Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine, 33: 419–31.
He, X, Li, Z, Chen, Y (2012) Efficacy of cognitive behavioral therapy for anxiety in females with first-episode paranoid schizophrenia. Medical Journal of Chinese People's Health, 24: 651–3.
Higgins, JPT, Green, S (eds) (2011) Part 2: General methods for Cochrane reviews. In Cochrane Handbook for Systematic Reviews of Interventions: Version 5.1.0. Cochrane Collaboration.
Horvath, AO, Symonds, BD (1991) Relation between working alliance and outcome in psychotherapy: a meta-analysis. Journal of Counseling Psychology, 38: 139–49.
Jones, C, Hacker, D, Xia, J, et al. (2018a) Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia. Cochrane Database of Systematic Reviews, 12: CD007964 (doi: 10.1002/14651858.CD007964.pub2).
Jones, C, Hacker, D, Meaden, A, et al. (2018b) Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia. Cochrane Database of Systematic Reviews, 11: CD008712 (doi: 10.1002/ 14651858.CD008712.pub3).
Karver, MS, Handelsman, JB, Fields, S, et al. (2006) Meta-analysis of therapeutic relationship variables in youth and family therapy: the evidence for different relationship variables in the child and adolescent treatment outcome literature. Clinical Psychology Review, 26: 50–65.
Kingdon, DG, Ashcroft, K, Bhandari, B, et al. (2010) Schizophrenia and borderline personality disorder: similarities and differences in the experience of auditory hallucinations, paranoia, and childhood trauma. Journal of Nervous and Mental Disease, 198: 399–403.
Kuipers, E, Garety, P, Fowler, D, et al. (1997) London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry, 171: 319–27.
Lehman, ALJ, Dixon, L (2004) APA practice guidelines: Schizophrenia. American Journal of Psychiatry, 161(Suppl 2): 1–56.
Li, X, Guo, Y, Fu, C, et al. (2014) Clinical efficiency and safety of CBT combined with low-dose risperidone alliance treatment on auditory hallucination in schizophrenia patients. Sichuan Mental Health, 27: 502–4.
Martin, DJ, Garske, JP, Davis, MK (2000) Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. Journal of Consulting and Clinical Psychology, 68: 438–50.
Naeem, F, Farooq, S, Kingdon, D (2015) Cognitive behavioural therapy (brief versus standard duration) for schizophrenia. Cochrane Database of Systematic Reviews, 10: CD010646 (doi: 10.1002/14651858.CD010646.pub3).
National Institute for Health and Care Excellence (2014) 1 Recommendations. In Psychosis and Schizophrenia in Adults: Prevention and Management . NICE.
Pan, S (2012) Cognitive therapy in the care of schizophrenic depression. Xin Li Yisheng, 7: 206–7.
Royal College of Psychiatrists (2018) National Clinical Audit of Psychosis: National Report for the Core Audit 2018. Healthcare Quality Improvement Partnership.
Schermuly-Haupt, M-L, Linden, M, Rush, AJ (2018) Unwanted events and side effects in cognitive behavior therapy. Cognitive Therapy and Research, 42: 219–29.
Schünemann, H, Brożek, J, Guyatt, G, et al. (2013) GRADE Handbook. GRADE.
Sibbald, B, Roberts, C (1998) Understanding controlled trials: crossover trials. BMJ, 316: 1719.
Startup, M, Jackson, MC, Startup, S (2004) Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease, 194: 740–50.
Wang, Z, Guo, Z, Han, G, et al. (2015) Efficacy of cognitive-behavioral therapy in community schizophrenia patients. China Journal of Health Psychology, 23: 16–9.